1Global tuberculosis control: epidemiology, strategy, financing: WHO reoort 2009.
2~lobal tuberculosis control : WHO report 2010.
3Markowitz N, Hansen NI, Wilcosky TC, et al. Tuberculin and anergy testing in HIV-seropositive and HIV-seronegative person. Pulmonary Complication of HIV Infection Study Group. Ann Intern Med, 1993, 119 : 185-193.
4Friedman H, Newton C, Klein TW. Microbial infections, immunomodulation, and drugs of abuse. Clin Micmbiol Rev, 2003, 16:209-219.
5Reichman LB, Felton CP, Edsall JR. Drug dependence, a possible new risk factor for tuberculosis disease. Arch Intern Med, 1979, 139:337-339.
6Alpert PL, Munsiff SS, Gourevitch MN, et al. A prospective study of tuberculosis and human immunodeficiency virus infection: clinical manifestations and factors associated with survival. Clin Infect Dis, 1997,24:661-668.
9Use of QuantiFERON -TB Gold In Tube assay to estimate the prevalence of M. Tuberculosis infection among injection drug user at risk for HIV in Tijuana,Mexico.
10Lalvani A. Diagnosing tuberculosis infection in the 21st century. New tools to tackle an old enemy. Chest,2007,131:1898-1906.
